 WALTHAM, Mass., March 03, 2021 GLOBE NEWSWIRE -- Repligen Corporation NASDAQ:RGEN, a life sciences company focused on bioprocessing technology leadership, today announced that it will present virtually at the Barclays Global Healthcare Conference being held March 9-11. Jon Snodgres, Chief Financial Officer, will participate in a fireside chat on Wednesday, March 10, at 1:50 p.m. EST. 